APA (7th ed.) Citation

Lichtenstein, G. R., Bressler, B., Francisconi, C., Vermeire, S., Lawendy, N., Salese, L., . . . Loftus, E. V. (2023). Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program. Inflammatory bowel diseases, 29(1), 27-41. https://doi.org/10.1093/ibd/izac084

Chicago Style (17th ed.) Citation

Lichtenstein, Gary R., et al. "Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program." Inflammatory Bowel Diseases 29, no. 1 (2023): 27-41. https://doi.org/10.1093/ibd/izac084.

MLA (9th ed.) Citation

Lichtenstein, Gary R., et al. "Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program." Inflammatory Bowel Diseases, vol. 29, no. 1, 2023, pp. 27-41, https://doi.org/10.1093/ibd/izac084.